jrnl3828

Publication Venue For

  • Observed Colposcopy Practice in US Community-Based Clinics: The Retrospective Control Arm of the IMPROVE-COLPO Study.  23:110-115. 2019
  • The impact of racial, geographic, and socioeconomic risk factors on the development of advanced-stage cervical cancer.  22:269-273. 2018
  • High Rates of High-Grade Cervical Dysplasia in High-Risk Young Women with Low-Grade Cervical Cytology.  22:207-211. 2018
  • In Defense of a Simplified, Practical Colposcopic Terminology.  22:233-234. 2018
  • ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States.  21:242-248. 2017
  • ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards.  21:235-241. 2017
  • ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice.  21:230-234. 2017
  • ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.  21:223-229. 2017
  • Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.  21:216-222. 2017
  • Frequency of Adequate Endometrial Biopsy in Evaluation of Postmenopausal Women with Benign Endometrial Cells on Pap Test.  21:258-260. 2017
  • Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.  21:87-90. 2017
  • Predictors of Positive Margins at Time of Loop Electrosurgical Excision Procedure.  21:64-66. 2017
  • Lack of Agreement between Endocervical Brush and Endocervical Curettage in Women Undergoing Repeat Endocervical Sampling.  20:296-299. 2016
  • Trends in Colposcopy Volume: Where Do We Go from Here?.  20:292-295. 2016
  • See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology?.  20:243-246. 2016
  • A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.  20:119-125. 2016
  • Adherence to Management Recommendations in Patients Diagnosed with Cervical Intraepithelial Neoplasia 2 or 3.  20:44-46. 2016
  • Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study.  20:47-51. 2016
  • Hydrostatic injury surgical planning.  19:e40-e42. 2015
  • Perinatal High-Grade Cervical Cytology: A Case Series from a Safety Net Institution.  19:329-332. 2015
  • Preference for human papillomavirus-based cervical cancer screening: Results of a choice-based conjoint study in Zambia.  19:119-123. 2015
  • Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance.  19:91-96. 2015
  • Screening behaviors and cultural barriers in women with newly diagnosed cervical cancer..  17:425-429. 2013
  • 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.  17. 2013
  • High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the cervista HPV HR test.  17:51-57. 2013
  • Invasive cervical cancer and screening: What are the rates of unscreened and underscreened women in the modern era?.  15:110-113. 2011
  • Referral patterns and incidence of cervical intraepithelial neoplasia in adolescent and pregnant patients: The impact of the 2006 guidelines.  15:124-127. 2011
  • Anal-rectal cytology: Correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients.  14:90-96. 2010
  • The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia.  13:137-144. 2009
  • The management of cervical intraepithelial neoplasia during pregnancy: Is colposcopy necessary?.  13:182-185. 2009
  • p16 improves interobserver agreement in diagnosis of anal intraepithelial neoplasia.  13:145-153. 2009
  • Diagnostic loop electrosurgical excisional procedure for discrepancy: Do preoperative factors predict presence of significant cervical intraepithelial neoplasia?.  11:69-72. 2007
  • Autoclave sterilization of instruments used on women with cervical neoplasia is an effective method of eradicating residual human papillomavirus DNA: A polymerase chain reaction-based evaluation.  11:12-17. 2007
  • Gene expression profiling of women with varying degrees of cervical intraepithelial neoplasia.  11:25-28. 2007
  • Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections.  10:213-218. 2006
  • Hormonal contraception and false-positive cervical cytology: Is there an association?.  10:102-106. 2006
  • A prospective evaluation of "see and treat" in women with HSIL Pap smear results: Is this an appropriate strategy?.  9:2-6. 2005
  • A cost-effectiveness analysis of screening strategies for cervical intraepithelial neoplasia.  8:280-284. 2004
  • High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in a population with human immunodeficiency virus.  8:298-303. 2004